103 related articles for article (PubMed ID: 3806964)
1. [Quantitative variations of lymphocyte subsets in various kinds of cancer patients in the terminal stage].
Nakajima Y; Akimoto M; Iwasaki H; Matano S; Hirakawa H; Kimura M
Gan No Rinsho; 1986 Dec; 32(15):1925-8. PubMed ID: 3806964
[TBL] [Abstract][Full Text] [Related]
2. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
Nakao S; Hayashida K; Hasegawa H; Ishii T; Eida K; Noguchi K
Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
[TBL] [Abstract][Full Text] [Related]
3. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
[TBL] [Abstract][Full Text] [Related]
4. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
5. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
6. [Studies of immunological function in patients with ovarian cancer].
Hamai J; Yakushiji M; Miyahara K; Okura N; Tazaki T; Nishimura H; Kato T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1875-82. PubMed ID: 2997348
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
Miyata T; Masuda H; Inoue T; Saeki K; Torisu M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):297-300. PubMed ID: 3341790
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppression: a paraneoplastic syndrome].
Nagel GA
Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
[No Abstract] [Full Text] [Related]
9. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
[TBL] [Abstract][Full Text] [Related]
10. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
11. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients].
Ochiai T; Sato H; Isono K; Uematsu T; Nakajima K; Mukai M; Asano T; Onoda S; Morioka Y; Danno M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):959-69. PubMed ID: 3963860
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cyclophosphamide on immunological responses in patients with breast cancer relating to BRM (biological response modifiers)].
Kimura M; Kanazawa K; Koida T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):549-53. PubMed ID: 3873910
[TBL] [Abstract][Full Text] [Related]
13. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of immunological response by ascitic fluid from gastrointestinal cancer patients].
Amemiya K
Nihon Geka Gakkai Zasshi; 1983 Dec; 84(12):1229-36. PubMed ID: 6201709
[TBL] [Abstract][Full Text] [Related]
15. [Radioimmunoassay of carcinoembryogenic antigen (CEA) in patients with carcinoma. Conclusion from preliminary results of a collaborative study in Switzerland].
Mach JP; Pusztaszeri G; Dysli M; Kapp F; Bierens de Haan B; Loosli RM; Grob P; Isliker H
Schweiz Med Wochenschr; 1973 Mar; 103(10):365-71. PubMed ID: 4120789
[No Abstract] [Full Text] [Related]
16. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors.
Di Girolamo V; Laguens RP; Coronato S; Salas M; Spinelli O; Portiansky E; Laguens G
J Exp Clin Cancer Res; 2000 Jun; 19(2):155-9. PubMed ID: 10965811
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies to thyroglobulin in patients with cancer].
Bershteĭn LM; Golubev VN; L'vovich EG; Dil'man VM
Vopr Onkol; 1977; 23(5):14-8. PubMed ID: 888413
[TBL] [Abstract][Full Text] [Related]
18. [The effect of surgical and nutritional treatment on activation parameters of peripheral blood T lymphocytes in stomach cancer patients in postoperative period].
Osada J; Kamocki Z; Rusak M; Dabrowska M; Kedra B
Pol Merkur Lekarski; 2008 Mar; 24(141):231-6. PubMed ID: 18634289
[TBL] [Abstract][Full Text] [Related]
19. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
[TBL] [Abstract][Full Text] [Related]
20. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
